EU Provides Horizon Discovery $1.7M to Develop Cancer Models
March 31, 2011
EU Provides Horizon Discovery $1.7M to Develop Cancer Models
The UK firm also joined the COLTHERES Consortium, tasked to define and carry out biomarker-driven clinical trials with the goal of improving cancer therapy outcomes.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.